fbpx

U.S. Anti-Doping Agency (USADA)

USADA logo.

Global DRO logo in whiteSearch Medications & Ingredients

Science Symposium

Since 2002, USADA has hosted the Annual USADA Symposium on Anti-Doping Science, aimed at bringing together anti-doping experts from around the world, including guests from more than 30 countries, to inform and shape meaningful anti-doping research programs for the future.

The attendees consist of WADA-accredited laboratories, anti-doping organizations, International Federations of the Olympic Movement, and scientific experts in the field of interest for each particular Symposium. A limited number of attendees are invited to attend the Symposium in order to provide a forum for exchanging scientific information.

The Symposium enables our attendees to stay up-to-date with the latest research and scientific developments in anti-doping and provides a unique opportunity to meet with peers and colleagues in their field.

Every year, the Symposium focuses on a key topic relevant to anti-doping science at that time. Read below for information regarding each Symposium.

EMERGING DRUGS and TECHNOLOGIES

18th Annual USADA Symposium on Anti-Doping Science
In Partnership with the Japan Anti-Doping Agency
October 4-7, 2019
Tokyo, Japan

JADA-USADA Symposium logo
Group photo of attendees of the 2019 Science Symposium in Japan.

On the eve of the Tokyo 2020 Olympic and Paralympic Games, employing state-of-the-art technology and innovative solutions remains of critical importance to uphold clean sport, counteract athletes’ attempts to evade detection, and conduct credible anti-doping programs. The 18th Annual Symposium will focus on the technical aspects of emerging drugs and technologies and their potential impact on anti-doping testing. The evolution of mass spectrometry into high resolution/high accuracy instrumentation continually increases the sensitivity and specificity of target analytes with further advances in isolation, identification, multiplexing, and quantifying proteins and peptides. In addition, the continued improvement of practical and predictive approaches to target testing through new sample collection techniques, performance modelling, pattern analysis, and adoption of artificial intelligence solutions is imperative to test the right athletes at the right time to maintain effective deterrence.

Explore Past Symposia

Chicago, Illinois - 2018

Biomarker Discovery & Application to Doping Detection & Deterrence

Orlando, Florida - 2017

Pharmacokinetics and Detection Windows: Interpretation of Long Term Metabolism and Excretion

Bellevue, Washington - 2016

Recovery, Repair, and Regeneration: From Steroids to Stem Cells

Lansdowne, Virginia - 2015

Designing an Effective Deterrence Program

Phoenix, Arizona - 2014

Stimulation of Erythropoiesis and O2 Utilization

Indianapolis, Indiana - 2013

Inside the Individual:  Refining the Measurement of Biological Variation

Atlanta, Georgia - 2012

Deterring Athletes from Using Performance-Enhancing Drugs

London, England - 2011

Detection of Growth Factors

Lansdowne, Virginia - 2010

Emerging Technologies

Vancouver, BC, Canada - 2009

Detection of Enhancement of O2 Transport: Seven Years of Progress

Colorado Springs, Colorado 2008

Mitochondria to Proteins: New Challenges for Anti-Doping Science

Dallas, Texas - 2007

Oxygen Transport and Energy Production

Lausanne, Switzerland - 2006

Intra-Individual Reference Ranges

Chicago, Illinois - 2005

Muscle Development & Recovery: Implications for Doping Control

Dallas, Texas - 2004

Detection of Human Growth Hormone Abuse in Sport

Los Angeles, California - 2003

Application of Gas Chromatography – Combustion – Isotope Ratio Mass Spectrometry to Doping Control

Atlanta, Georgia - 2002

Oxygen Transport Enhancing Agents and Methods

Scroll to Top

ACHIEVEMENTS OF THE SCIENCE SYMPOSIUM VIDEO TRANSCRIPT

LARRY BOWERS, Former USADA Chief Science Officer:

Probably the one that stands out most in my mind in terms of achievements of the symposium was in 2004, we actually moved the symposium from October back to April. And the reason that we did that was that there were possibilities for growth hormone testing that had not had serious, peer scientific review. So, we talked with the IOC, we talked with WADA, and we that decided April was the last possible moment that we could decide whether or not there would be a growth hormone test employed at the Olympic Games in Athens. And so, we assembled all the experts in the world on growth hormone and growth hormone testing in Dallas, and we had a three day meeting discussing the testing, and the outcome of that was, that they were going to use one of the two growth hormone tests that had been developed at the Games in Athens. I still remember meeting in my hotel suite after the meeting or at the end of the meeting with Patrick Schamasch of the IOC and Costas from the Greek lab and several other people to talk about how to roll this out and how important this was to the movement. So, that was a big one.